Cargando…
Coronavirus membrane fusion mechanism offers a potential target for antiviral development
The coronavirus disease 2019 (COVID-19) pandemic has focused attention on the need to develop effective therapies against the causative agent, SARS-CoV-2, and also against other pathogenic coronaviruses (CoV) that have emerged in the past or might appear in future. Researchers are therefore focusing...
Autores principales: | Tang, Tiffany, Bidon, Miya, Jaimes, Javier A., Whittaker, Gary R., Daniel, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194977/ https://www.ncbi.nlm.nih.gov/pubmed/32272173 http://dx.doi.org/10.1016/j.antiviral.2020.104792 |
Ejemplares similares
-
Feline coronavirus: Insights into viral pathogenesis based on the spike protein structure and function
por: Jaimes, Javier A., et al.
Publicado: (2018) -
Single particle assay of coronavirus membrane fusion with proteinaceous receptor-embedded supported bilayers
por: Costello, Deirdre A., et al.
Publicado: (2013) -
Molecular diversity of coronavirus host cell entry receptors
por: Millet, Jean K, et al.
Publicado: (2020) -
Mechanisms of Coronavirus Genome Stability As Potential Targets for Antiviral Drugs
por: Yuyukina, S. K., et al.
Publicado: (2022) -
Membrane fusion, potential threats, and natural antiviral drugs of pseudorabies virus
por: Ye, Ni, et al.
Publicado: (2023)